Health & ScienceAustralian therapy aiming to halt motor neurone disease advances to national Phase 2 trial
NuNerve’s NUN-004 will be tested in 75 participants across six Australian sites after an early study showed disease stabilisation and functional improvement in people living with motor neurone disease.
Health & Science · 10 Nov 2026, 12:59 pm